Pharmacy News Article

Item 8.01. Other Events

On July 30, 2010, the Company publicly disseminated a press release announcing that the U.S. Food and Drug Administration (FDA) has lifted the prior clinical hold of the Company's Investigational New Drug (IND) application for the Phase 1 clinical trial of GRNOPC1 in patients with acute spinal cord injury.

The foregoing description is qualified in its entirety by reference to the Company's Press Release dated July 30, 2010, a copy of which is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

             99.1   Press release dated July 30, 2010.